Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.66 |
| ▸ | GAA | P10253 | 1/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | MAOA | P21397 | 1/20 | 0.49 |
| ▸ | MAOB | P27338 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 8/20 | 0.47 |
| ▸ | CA2 | P00918 | 8/20 | 0.47 |
| ▸ | CA12 | O43570 | 6/20 | 0.47 |
| ▸ | CA9 | Q16790 | 6/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.45 |
| ▸ | CTSK | P43235 | 4/20 | 0.44 |
| ▸ | CTSS | P25774 | 3/20 | 0.43 |
| ▸ | STK17B | O94768 | 1/20 | 0.42 |
| ▸ | STK17A | Q9UEE5 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CTSL | P07711 | 1/20 | 0.41 |
| ▸ | CTSB | P07858 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL902132 | 1.00 | MEN1 (0.66) | MEN1GAAKMT2ATDP1MAOA | |
| SCHEMBL10140672 | 0.95 | MEN1 (0.59) | MEN1GAAKMT2ATDP1MAOA | |
| SCHEMBL902008 | 0.95 | MEN1 (0.59) | MEN1GAAKMT2ATDP1MAOA | |
| SCHEMBL6837317 | 0.94 | TDP1 (0.61) | MEN1GAAKMT2ATDP1MAOA | |
| SCHEMBL13055386 | 0.90 | MEN1 (0.56) | MEN1GAAKMT2ATDP1MAOA | |
| SCHEMBL26496672 | 0.85 | MEN1 (0.47) | MEN1GAAKMT2ATDP1MAOA | |
| SCHEMBL14405152 | 0.84 | MEN1 (0.72) | MEN1GAAKMT2ATDP1MAOA | |
| SCHEMBL30299126 | 0.84 | TDP1 (0.50) | MEN1GAAKMT2ATDP1MAOA | |
| SCHEMBL19301000 | 0.84 | MEN1 (0.62) | MEN1GAAKMT2ATDP1MAOA | |
| SCHEMBL24687980 | 0.83 | TDP1 (0.50) | MEN1GAAKMT2ATDP1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017147335-A1 | BACTERIAL EFFLUX PUMP INHIBITORS | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2017-08-31 | — | — | WO | disclosed |
| US-20050131230-A1 | Method and associated compounds for forming nanotubes | NATIONAL SCIENCE FOUNDATION | 2005-06-16 | — | — | US | disclosed |
| US-6696565-B2 | SELF-ASSEMBLING; PHYSICAL PROPERTIES; THERMOCONDUCTIVITY | PURDUE RESEARCH FOUNDATION | 2004-02-24 | — | — | US | disclosed |
| US-20020151556-A1 | Method and associated compounds for forming nanotubes | PURDUE RESEARCH FOUNDATION | 2002-10-17 | — | — | US | disclosed |
| WO-2002066482-A1 | METHOD AND ASSOCIATED COMPOUNDS FOR FORMING NANOTUBES | PURDUE RESEARCH FOUNDATION (US) | 2002-08-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050131230-A1 | Method and associated compounds for forming nanotubes | TUBB6, TUBB4A, TUBB4B | MEN1 2302/4885GAA 2442/4885KMT2A 3183/4885 |
| US-20020151556-A1 | Method and associated compounds for forming nanotubes | TUBB6, TUBB4A, TUBB4B | MEN1 2302/4885GAA 2442/4885KMT2A 3183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.